In the race to develop medication, test kits and vaccines aimed at COVID-19, Eternal Materials Co (長興材料), a company known for its chemical exports, has emerged as a dark horse.
Its rapid test kit for COVID-19 antibodies was one of the first to be manufactured in Taiwan, and it was used to test people linked to the largest cluster infection of COVID-19 seen in the country back in April.
Eternal Materials has now received formal approval to sell the product in Taiwan, as well as in the EU and several Southeast Asian countries, and it is applying for a permit in the US, company spokesman Liu Bing-cheng (劉秉誠) said.
Photo: CNA
“Without our previous experience, we wouldn’t have had this opportunity,” chief operating officer Mao Hui-kuan (毛惠寬) said in a recent interview, referring to seven rocky years endured by Eternal Materials’ biomedical research team.
Founded in 1964, the company is one of the largest suppliers of synthetic resins and photoresist materials in Asia. It ventured into the biomedical field in 2013, with a focus on test kits.
Although some of its products have proved useful in disease prevention, such as a test kit for dengue fever that the company worked on with the Centers for Disease Control (CDC), none of them have been a commercial success.
Photo: CNA
“We’ve struggled a lot,” to the point where management has considered dismantling the department, Mao said.
Yet the team persevered, and the pandemic, despite its adverse impact on the company’s business earlier this year, proved to be an opportunity for its research and development staff to put their expertise to good use.
In March, the CDC contacted Eternal Materials to see if it could develop a rapid test for detecting COVID-19 antibodies. Within 10 days, it had a prototype ready to go.
“We just kept trying and trying and trying,” Eternal Materials chief researcher Wang Hsi-kai (王璽凱) said.
The prototype was just the beginning; researchers at Eternal Materials continued to revise and improve the test kit over the following months.
It was used by the Central Epidemic Command Center in late April to test for antibodies when a cluster infection linked to a navy flotilla emerged.
Five months after the development process officially began, the team settled on a finalized version of the kit and called it the Eternal COVIDual COVID-19 IgM/IgG Rapid Test.
That same month, it became the third COVID-19 antibody test in Taiwan to receive emergency use authorization from the Food and Drug Administration.
Results can be seen in 15 minutes, and can indicate whether a person was infected recently or in the more distant past, with an accuracy rate of 98 percent, the company said.
However, other countries started manufacturing antibody rapid test kits months ago, raising questions whether Taiwan might be too late to the game to have an impact in the global market.
Chen Wen-ching (陳玟瑾), a manager in the company’s development department, acknowledges the challenges of being a late entrant, but sees other factors at play, especially quality and reliability.
The market was awash with test kits from China in April and May, but Taiwanese products are popular globally and quality remains the deciding factor whether a product is bought, she said.
“Even though we are a bit late, our products are good,” she said.
The company has already begun selling the test kits in small quantities overseas as it scales up production, hoping to increase its monthly output to 1 million kits by the end of the year, Chen said.
The goal is to produce 3 million test kits a month by March next year, and 11 million per month by the end of next year, she said.
That timetable suggests it might be a while before profits start to roll in, but Mao is not worried.
“It’s still exciting to be able to contribute to society, and be a part of the ‘national team’ that is fighting the disease,” he said.
DIVIDED VIEWS: Although the Fed agreed on holding rates steady, some officials see no rate cuts for this year, while 10 policymakers foresee two or more cuts There are a lot of unknowns about the outlook for the economy and interest rates, but US Federal Reserve Chair Jerome Powell signaled at least one thing seems certain: Higher prices are coming. Fed policymakers voted unanimously to hold interest rates steady at a range of 4.25 percent to 4.50 percent for a fourth straight meeting on Wednesday, as they await clarity on whether tariffs would leave a one-time or more lasting mark on inflation. Powell said it is still unclear how much of the bill would fall on the shoulders of consumers, but he expects to learn more about tariffs
NOT JUSTIFIED: The bank’s governor said there would only be a rate cut if inflation falls below 1.5% and economic conditions deteriorate, which have not been detected The central bank yesterday kept its key interest rates unchanged for a fifth consecutive quarter, aligning with market expectations, while slightly lowering its inflation outlook amid signs of cooling price pressures. The move came after the US Federal Reserve held rates steady overnight, despite pressure from US President Donald Trump to cut borrowing costs. Central bank board members unanimously voted to maintain the discount rate at 2 percent, the secured loan rate at 2.375 percent and the overnight lending rate at 4.25 percent. “We consider the policy decision appropriate, although it suggests tightening leaning after factoring in slackening inflation and stable GDP growth,”
Meta Platforms Inc offered US$100 million bonuses to OpenAI employees in an unsuccessful bid to poach the ChatGPT maker’s talent and strengthen its own generative artificial intelligence (AI) teams, OpenAI CEO Sam Altman has said. Facebook’s parent company — a competitor of OpenAI — also offered “giant” annual salaries exceeding US$100 million to OpenAI staffers, Altman said in an interview on the Uncapped with Jack Altman podcast released on Tuesday. “It is crazy,” Sam Altman told his brother Jack in the interview. “I’m really happy that at least so far none of our best people have decided to take them
As they zigzagged from one machine to another in the searing African sun, the workers were covered in black soot. However, the charcoal they were making is known as “green,” and backers hope it can save impoverished Chad from rampant deforestation. Chad, a vast, landlocked country of 19 million people perched at the crossroads of north and central Africa, is steadily turning to desert. It has lost more than 90 percent of its forest cover since the 1970s, hit by climate change and overexploitation of trees for household uses such as cooking, officials say. “Green charcoal” aims to protect what